Cargando…
Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1
BACKGROUND: There are around 350 million of hepatitis B surface antigen (HBsAg) carriers worldwide, and among them, high risk of developing hepatocellular carcinoma (HCC) has been identified by epidemiological studies. To date, the molecular role of HBsAg in HCC development has not been fully studie...
Autores principales: | Tian, Xiaochen, Li, Jinjun, Ma, Zhang-Mei, Zhao, Chao, Wan, Da-Fang, Wen, Yu-Mei |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678988/ https://www.ncbi.nlm.nih.gov/pubmed/19402906 http://dx.doi.org/10.1186/1756-9966-28-58 |
Ejemplares similares
-
Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection
por: Yang, Wan-Ting, et al.
Publicado: (2016) -
Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma.
por: Tsai, J. F., et al.
Publicado: (1996) -
Fetal antigens on the surface of human lymphoid cells
Publicado: (1976) -
Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas
por: Fang, Tao, et al.
Publicado: (2015) -
miR-300 regulates tumor proliferation and metastasis by targeting lymphoid enhancer-binding factor 1 in hepatocellular carcinoma
por: Chen, Yufo, et al.
Publicado: (2019)